Portfolio · Therapeutic Categories
Four categories, evaluated the same way.
Our portfolio offers best-in-class medicines across four therapeutic categories.
Every category, regardless of volume or margin, is evaluated through VAIS™ against the same generational benchmarking, manufacturing-quality threshold, and registration-feasibility mapping. A further eleven categories are under active evaluation on our Pipeline page.
